Jan 7 (Reuters) - Cynapsus Therapeutics Inc CTH.TO :
* Press release - Cynapsus and Michael J. Fox foundation collaborate on pilot
use of wearable device and data science approaches in phase 3 parkinson's
clinical study
* Says phase 3 results on the safety and efficacy of apl-130277 are expected in
2016
* Source text for Eikon
* Further company coverage CTH.TO